1. Brodsky, M., Elliott, K., Hynasky, A. and Inturrisi, C.E., CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone, Brain Res. Bull., 38 (1995) 135–141.
2. Brodsky, M., Elliott, K.J., Hynasky, A., Jenab, S. and Inturrisi, C.E., Quantitative distribution of the mu opioid receptor mRNA in the rat CNS, NeuroReport, 6 (1995) 725–729.
3. Chen, Y., Mestek, A., Liu, J., Hurley, J.A. and Yu, L., Molecular cloning and functional expression of a mu opioid receptor from rat brain, Mol. Pharmacol., 44 (1993) 8–12.
4. Cicero, T.J., Schainker, B.A. and Meyer, E.R., Endogenous opioids participate in the regulation of the hypothalamic-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone, Endocrinology, 104 (1979) 1286–1291.
5. Eckersell, C.B., Priest, C.A. and Micevych, P.E., Temporal regulation of preproenkephalin-A (PPE-A) mRNA expression by estrogen in the posterior dorsal medial amygdala, Soc. Neurosci. Abstr., 21 (1994) 725.1. (Abstract).